Treatment of cerebral infarction using autologous marrow mesenchymal stem cells transplantation:A six-month follow-up

Meng Xian-guo,Zhu Shi-wen,Gao Hua,Li Yi-zhao,Shi Qing,Hou Huai-shui,Li Dong
DOI: https://doi.org/10.3969/j.issn.1673-8225.2009.32.036
2009-01-01
Abstract:OBJECTIVE:To observe the curative effect and safety of autologous marrow mesenchymal stem cells(MSCs) transplantation on treating cerebral infarction.METHODS:Totally 120 cerebral infarction patients enrolled at the Qilu Hospital of Shandong University from June 2003 to June 2008 was collected,and diagnosed as ischemic stroke according to the diagnosis standard published on the collection of National Fourth Cerebral Vascular Disease Conference.All patients were divided into control,stem cell mobilization,stem cell transplantation,and combined treatment groups,with 30 cases in each group.In the control group patients were treated with routine medication and rehabilitation training.Patients in the stem cell mobilization group were received 150 μg filgrastim at abdominal subcutaneous injection as well as the routine medication.In the stem cell transplantation group,patients were vein transplanted(16.2-51.3)×108 MSCs based on the routine medication.In the combined treatment group,the above methods performed simultaneously.RESULTS:Compared to the control group,scoring with Fugl-Meyer(FMA) and Function Independence Measure(FIM) was obvious improved in the other groups at the weeks 4,12 and months 6 after treatment(P < 0.05 or P < 0.01),especially in the combined treatment group,the curative effect of which was superior to stem cell mobilization and stem cell transplantation groups(P < 0.05).Within 14 days after treatment,no adverse effect appeared in the stem cell mobilization group;4 patients had fever in the stem cell transplantation group,with body temperature below 38 ℃ and returned to a normal level after 24 hours,3 patients suffered mild headache and released after 24 hours without treatment;in the combined treatment group,4 patients had fever with body temperature below 38 ℃ and returned to a normal level after 24 hours,3 patients suffered mild headache and released after 24 hours without treatment.CONCLUSION:MSCs transplantation obtains an excellent curative effect on treating cerebral infarction,and the adverse effects are few.
What problem does this paper attempt to address?